Harding Loevner’s Idexx Laboratories IDXX Stock Holding History

Harding Loevner’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-70	Closed	-$23K	–	116
2022 Q3	$23K	Hold	70	–	–	﹤0.01%	120
2022 Q2	$25K	Hold	70	–	–	﹤0.01%	120
2022 Q1	$24K	Hold	70	–	–	﹤0.01%	119
2021 Q4	$46K	Hold	70	–	–	﹤0.01%	113
2021 Q3	$44K	Hold	70	–	–	﹤0.01%	106
2021 Q2	$44K	Hold	70	–	–	﹤0.01%	109
2021 Q1	$34K	Hold	70	–	–	﹤0.01%	123
2020 Q4	$35K	Hold	70	–	–	﹤0.01%	120
2020 Q3	$28K	Hold	70	–	–	﹤0.01%	153
2020 Q2	$23K	Hold	70	–	–	﹤0.01%	120
2020 Q1	$17K	Hold	70	–	–	﹤0.01%	123
2019 Q4	$18K	Hold	70	–	–	﹤0.01%	125
2019 Q3	$19K	Hold	70	–	–	﹤0.01%	120
2019 Q2	$19K	Hold	70	–	–	﹤0.01%	125
2019 Q1	$16K	Hold	70	–	–	﹤0.01%	123
2018 Q4	$13K	Hold	70	–	–	﹤0.01%	130
2018 Q3	$17K	Hold	70	–	–	﹤0.01%	123
2018 Q2	$15K	Hold	70	–	–	﹤0.01%	125
2018 Q1	$13K	Hold	70	–	–	﹤0.01%	140
2017 Q4	$11K	Hold	70	–	–	﹤0.01%	128
2017 Q3	$11K	Hold	70	–	–	﹤0.01%	123
2017 Q2	$11K	Buy	+70	New	+$11.4K	﹤0.01%	119

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harding Loevner's IDXX Position: Q4 2022 in Review

Harding Loevner sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 70 shares — an estimated $23K sold.

Harding Loevner first reported a position in IDXX in Q2 2017 and held it in 22 quarters. The position peaked at $46K in Q4 2021. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

Harding Loevner reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
Harding Loevner sold 70 Idexx Laboratories shares in Q4 2022, an estimated $23K.
Harding Loevner first reported a position in Idexx Laboratories in Q2 2017 and held it in 22 quarters.
Harding Loevner's Idexx Laboratories position peaked at $46K in Q4 2021.
999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Harding Loevner's 13F filing for Q4 2022, filed 14 Feb 2023.